Phospholipase Inhibitors

Phospholipase A

PLD

Phospholipase Inhibitors & Antagonists

Product Name	Phospholipase A	PLD	Purity
A3373		PLD1, IC₅₀: 325 nM PLD2, IC₅₀: 15.15 μM	99.06%
Varespladib	sPLA2, IC₅₀: 9 nM		99.94%
Bromoenol lactone	PLA2, IC₅₀: 7 μM		98.41%
1-Naphthaleneacetic acid	PLA2, IC₅₀: 13.16 μM		99.89%
Pyrrophenone	cPLA2α, IC₅₀: 4.2 nM		99.76%
VU0155069		PLD1, IC₅₀: 46 nM PLD2, IC₅₀: 933 nM	98.04%
Halopemide		PLD1, IC₅₀: 220 nM PLD2, IC₅₀: 310 nM	99.65%
OBAA	PLA2, IC₅₀: 70 nM		99.27%
PACOCF3	PLA2, IC₅₀: 3.8 μM		≥98.0%
VU0359595		PLD1, IC₅₀: 3.7 nM PLD2, IC₅₀: 6.4 μM	99.65%
sPLA2 inhibitor 1	sPLA2, IC₅₀: 29 nM		99.47%
Rapanone	PLA2, IC₅₀: 2.6 μM		99.20%
Alminoprofen	sPLA2		99.91%
trans-Benzylideneacetone	PLA2		99.29%
CAY10502	cPLA2α, IC₅₀: 4.3 nM		≥99.0%
(S)-Bromoenol lactone	PLA2		≥99.0%
VU533		PLD1, EC₅₀: 0.3 μM	99.71%
CAY10590	sPLA2		≥98.0%
(Z)-Oleyloxyethyl phosphorylcholine	sPLA2
Lp-PLA2-IN-1	Lp-PLA2		99.18%
Giripladib	cPLA2α		99.68%
Varespladib sodium	sPLA2, IC₅₀: 9 nM		≥98.0%
BML-280		PLD2 PLD1	99.64%
1-Naphthaleneacetic acid potassium salt	PLA2, IC₅₀: 13.16 μM		99.64%
Lp-PLA2-IN-2	Lp-PLA2, IC₅₀: 120 nM
YM-26734	sPLA2
VI-60	cPLA₂
Efipladib	cPLA2α, IC₅₀: 0.04 μM cPLA2α, Ki: 0.067 μM
VU0155069 hydrochloride		PLD1, IC₅₀: 46 nM
SB-435495 hydrochloride	Lp-PLA2, IC₅₀: 0.06 nM
Protizinic acid	PLA2, IC₅₀: 210 μM
VU 0364739 hydrochloride		PLD2, IC₅₀: 20 nM PLD1, IC₅₀: 1500 nM
AX048	cPLA₂
Lp-PLA2-IN-14	rhLp-PLA2, pIC₅₀: 8.4
SB-435495 ditartrate	Lp-PLA2, IC₅₀: 0.06 nM
Me-Indoxam	sPLA2
SB-435495	Lp-PLA2, IC₅₀: 0.06 nM		99.80%
FKGK11	PLA2
LY 178002	PLA2, IC₅₀: 6.3 μM

Name
Email *

	Sorry, but the email address you supplied was invalid.